Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Lactational exposure to hexavalent chromium delays puberty by impairing ovarian development, steroidogenesis and pituitary hormone synthesis in developing Wistar rats

Journal Article · · Toxicology and Applied Pharmacology
 [1];  [2];  [1];  [3]
  1. Reproductive Endocrinology and Cell Signaling Laboratory, Texas A and M University, TAMU 4458, College Station, Texas 77843 (United States)
  2. Department of Zoology, St. John's College, Palayamkottai, 627 002 (India)
  3. Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A and M University, TAMU 4458, College Station, Texas 77843 (United States)

Hexavalent chromium (Cr-VI) is used in a wide range of industries. Cr-VI from chromate industries and atmospheric emissions contribute to the Cr contamination in the environment. Cr is a reproductive metal toxicant that can traverse the placental barrier and cause a wide range of fetal effects including ovotoxicity. Therefore, the goal of this study was to investigate the basic mechanisms involved in Cr(VI)-induced ovotoxicity, and the protective role of vitamin C on ovarian follicular development and function in Cr(VI)-induced reproductive toxicity using both in vivo and in vitro approaches. Lactating rats received potassium dichromate (200 mg/L) with or without vitamin C (500 mg/L), through drinking water from postpartum days 1-21. During postnatal days (PND) 1-21 the pups received Cr(VI) via the mother's milk. Pups from both control and treatment groups were continued on regular diet and water from PND-21 onwards, and euthanized on PND-21, -45 and -65. Cr(VI) decreased steroidogenesis, GH and PRL, increased FSH and did not alter LH. Cr(VI) delayed puberty, decreased follicle number, and extended estrous cycle. Spontaneously immortalized rat granulosa cells were treated with 12.5 {mu}M (IC{sub 50}) potassium dichromate for 12 and 24 h, with or without vitamin C pre-treatment. Cr(VI) decreased the mRNA expressions of StAR, SF-1, 17{beta}-HSD-1, 17{beta}-HSD-2, FSHR, LHR, ER{alpha} and ER{beta}. Vitamin C pre-treatment protected ovary and granulosa cells from the deleterious effects of Cr(VI) toxicity, both in vivo and in vitro. Therefore, Cr(VI) toxicity could be a potential risk to the reproductive system in developing females, and vitamin C plays a protective role against Cr(VI)-induced ovotoxicity.

OSTI ID:
21144134
Journal Information:
Toxicology and Applied Pharmacology, Journal Name: Toxicology and Applied Pharmacology Journal Issue: 2 Vol. 232; ISSN TXAPA9; ISSN 0041-008X
Country of Publication:
United States
Language:
English

Similar Records

In vivo and in vitro effects of chromium VI on anterior pituitary hormone release and cell viability
Journal Article · Sun Dec 31 23:00:00 EST 2006 · Toxicology and Applied Pharmacology · OSTI ID:20976841

DEHP exposure in utero disturbs sex determination and is potentially linked with precocious puberty in female mice
Journal Article · Thu Sep 15 00:00:00 EDT 2016 · Toxicology and Applied Pharmacology · OSTI ID:22690795

Mechanisms of action underlying the antiandrogenic effects of the fungicide prochloraz
Journal Article · Thu Jun 01 00:00:00 EDT 2006 · Toxicology and Applied Pharmacology · OSTI ID:20850338